In addition to PD-1/PD-L1 and CTLA-4 as the most important immune checkpoints, emerging evidence indicates LAG3, TIM-3, TIGIT, VISTA, and other immune checkpoints are the representative ones in malignant tumor (Pardoll, 2012; Wei et al., 2018). The gene discussed is CTLA4; the disease is cancer.